Le Lézard
Classified in: Health, Science and technology
Subjects: SVY, MAT, MIN

When Men Truly Want Sex - Erobella's new analysis


BERLIN, March 18, 2024 /PRNewswire/ -- An analysis of the click rates on erobella.com, Germany's largest erotic portal, provides insightful glimpses into the sexual preferences of German men. Contrary to common beliefs, the study shows that men do not primarily exhibit increased sexual interest at night but at specific times of the day.

Surprising Peak Times

The data reveals that on Mondays at 12 PM and 4 PM, as well as on Sundays at 1 PM, there is a significant surge in demand for sexual content. These times, which sometimes unexpectedly fall into the workday or the relaxed weekend rhythm, could indicate a need for distraction, relaxation, or a pleasant start to the week.

Low Interest at Night and on Saturdays

Interestingly, there is a clear decline in sexual interest late at night and on Saturdays. This suggests that men are more likely to use this period for rest, hobbies, or social activities and have less interest in sexual pursuits.

Influence of Special Days and Events

Special days such as New Year's Day, the Champions League Final, or German Unity Day show significant deviations from average behavior. These data points illustrate how external events and holidays can influence sexual behavior.

This study challenges common assumptions and shows that men's sexual interest is more complex than often assumed. The results emphasize the importance of reconsidering stereotypes and taking into account the numerous factors that can influence sexual desire.

The full study is available here: https://erobella.com/lust/wann-die-meisten-maenner-wirklich-sex-wollen/

About Erobella

The erotic portal Erobella.com connects reputable providers of sexual services, escort companions, and models with genuine customers. Furthermore, Erobella is committed to the interests of sex workers in Germany and against the stigmatization of the industry. The portal regularly publishes studies and surveys, thus making an important contribution to societal enlightenment.

Contact : Fruzsina Lederer, [email protected], +36309141467

 

SOURCE Erobella


These press releases may also interest you

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...



News published on and distributed by: